AMPH R&D Expenses
Amphastar Pharmaceuticals Inc · R&D Expenses
AMPH R&D Expenses
Latest reported$94.57Mperiod ending
AMPH R&D Expenses ($31.05M → $94.57M)
Annual R&D Expenses
High-resolution chart · PNG
AMPH r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 85,844,000 | |
| 73,914,000 | |
| 73,741,000 | |
| 74,771,000 | |
| 60,932,000 | |
| 67,229,000 | |
| 68,853,000 | |
| 57,564,000 | |
| 43,415,000 | |
| 41,199,000 | |
| 37,065,000 | |
| 28,427,000 | |
| 33,019,000 | |
| 31,163,000 | |
| 31,049,000 |